Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment |
| |
| Authors: | V. von Wyl,B. F. D card,P. Benkert,J. Lorscheider,P. H nni,C. Lienert,J. Kuhle,T. Derfuss,L. Kappos,
. Yaldizli |
| |
| Affiliation: | V. von Wyl,B. F. Décard,P. Benkert,J. Lorscheider,P. Hänni,C. Lienert,J. Kuhle,T. Derfuss,L. Kappos,Ö. Yaldizli |
| |
| Abstract: | |
| |
| Keywords: | disability progression disease‐modifying drugs pediatric‐onset multiple sclerosis relapse rate |
|
|
